Prophylactic oral UFT therapy for superficial bladder cancer
- 1 March 1993
- Vol. 71 (5) , 1842-1845
- https://doi.org/10.1002/1097-0142(19930301)71:5<1842::aid-cncr2820710520>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- Preoperative doxorubicin instillation in recurrent superficial bladder cancerCancer Chemotherapy and Pharmacology, 1987
- Intravesical TherapyUrologic Clinics of North America, 1987
- The Effect of Intravesical Thiotepa on the Recurrence Rate of Newly Diagnosed Superficial Bladder Cancer. An MRC StudyBritish Journal of Urology, 1985
- Long-Term Mitomycin C Instillation After Transurethral Resection of Superficial Bladder Carcinoma: Influence on Recurrence, Progression and SurvivalJournal of Urology, 1984
- Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter studyCancer, 1984
- Intravesical Chemotherapy of Superficial Bladder CancerPublished by Springer Nature ,1983
- The Use of Intravesical Thio-Tepa in the Management of Non-invasive Carcinoma of the BladderJournal of Urology, 1981
- Bacillus Calmette-guerin Immunotherapy of Superficial Bladder CancerJournal of Urology, 1980